title: Biology and treatment of acute lymphocytic leukemia in adolescents and young adults.
abstract: The treatment of young adults (16 to 39 years of age) with acute lymphocytic leukemia (ALL) has been a focus of clinical research over the past decade. This review will focus on the biology, optimal treatment, treatment-related toxicities, and psychosocial issues in this patient population.
authors.affiliation: From The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
authors.forename: Anjali S
authors.initials: AS
authors.lastname: Advani
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002869:Chromosome Aberrations; D015973:Gene Expression Regulation, Leukemic; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D010349:Patient Compliance; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology* / Q000523:psychology* / Q000628:therapy*; D014184:Transplantation, Homologous; D055815:Young Adult